These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32886813)

  • 1. Very low probability of significant liver inflammation in chronic hepatitis B patients with low ALT levels in the absence of liver fibrosis.
    Sonneveld MJ; Brouwer WP; Hansen BE; Chan HL; Piratvisuth T; Jia JD; Zeuzem S; Chien RN; Choi H; de Knegt RJ; Wat C; Pavlovic V; Gaggar A; Xie Q; Buti M; de Man RA; Janssen HLA;
    Aliment Pharmacol Ther; 2020 Oct; 52(8):1399-1406. PubMed ID: 32886813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
    Sanai FM; Babatin MA; Bzeizi KI; Alsohaibani F; Al-Hamoudi W; Alsaad KO; Al Mana H; Handoo FA; Al-Ashgar H; Alghamdi H; Ibrahim A; Aljumah A; Alalwan A; Altraif IH; Al-Hussaini H; Myers RP; Abdo AA
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1493-1499.e2. PubMed ID: 23811251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of normal or minimally elevated alanine transaminase, age and DNA level in predicting liver histological changes in chronic hepatitis B.
    Alam S; Ahmad N; Mustafa G; Shrestha A; Alam AK; Khan M
    Liver Int; 2011 Jul; 31(6):824-30. PubMed ID: 21645213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shear wave elastography for liver fibrosis in chronic hepatitis B: Adapting the cut-offs to alanine aminotransferase levels improves accuracy.
    Zeng J; Zheng J; Jin JY; Mao YJ; Guo HY; Lu MD; Zheng HR; Zheng RQ
    Eur Radiol; 2019 Feb; 29(2):857-865. PubMed ID: 30039224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage.
    Wu IC; Lai CL; Han SH; Han KH; Gordon SC; Chao YC; Tan CK; Sievert W; Tanwandee T; Xu D; Neo BL; Chang TT
    Hepatology; 2010 Apr; 51(4):1185-9. PubMed ID: 20044806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels.
    Ormeci A; Aydın Y; Sumnu A; Baran B; Soyer OM; Pınarbasi B; Gokturk S; Gulluoglu M; Onel D; Badur S; Akyuz F; Karaca C; Demir K; Besisik F; Kaymakoglu S
    Int J Infect Dis; 2016 Nov; 52():68-73. PubMed ID: 27619844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of APRI and FIB-4 for noninvasive assessment of significant fibrosis and cirrhosis in HBeAg-negative CHB patients with ALT ≤ 2 ULN: A retrospective cohort study.
    Li Q; Ren X; Lu C; Li W; Huang Y; Chen L
    Medicine (Baltimore); 2017 Mar; 96(12):e6336. PubMed ID: 28328813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of significant liver fibrosis and cirrhosis in chronic hepatitis B patients with normal ALT in central Europe.
    Göbel T; Erhardt A; Herwig M; Poremba C; Baldus SE; Sagir A; Heinzel-Pleines U; Häussinger D
    J Med Virol; 2011 Jun; 83(6):968-73. PubMed ID: 21503908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant hepatic histopathology in chronic hepatitis B patients with serum ALT less than twice ULN and high HBV-DNA levels in Indonesia.
    Lesmana CR; Gani RA; Hasan I; Simadibrata M; Sulaiman AS; Pakasi LS; Budihusodo U; Krisnuhoni E; Lesmana LA
    J Dig Dis; 2011 Dec; 12(6):476-80. PubMed ID: 22118698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels.
    Park JY; Park YN; Kim DY; Paik YH; Lee KS; Moon BS; Han KH; Chon CY; Ahn SH
    J Viral Hepat; 2008 Aug; 15(8):615-21. PubMed ID: 18573162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
    Li Q; Li W; Huang Y; Chen L
    J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A scoring system for predicting significant fibrosis in chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase levels.
    Wang H; Yan R; Zhou Y; Wang MS; Ruo GQ; Cheng MJ
    J Clin Gastroenterol; 2015 Jan; 49(1):69-75. PubMed ID: 24518795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histologic evidence of active liver injury in chronic hepatitis B patients with normal range or minimally elevated alanine aminotransferase levels.
    Hu KQ; Schiff ER; Kowdley KV; Min AD; Shiffman ML; Lee WM; Goodman ZD; Dau LO; Peschell KJ; Fagan EA; Flaherty JF
    J Clin Gastroenterol; 2010 Aug; 44(7):510-6. PubMed ID: 20179614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristic of liver pathology in HBeAg-positive and HBeAg-negative chronic hepatitis B patients with mildly elevated ALT].
    Liu SQ; Zhu XJ; Sun XH; Li M; Gao YQ
    Zhonghua Gan Zang Bing Za Zhi; 2012 May; 20(5):348-52. PubMed ID: 22971279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Accuracy of FibroScan for the diagnosis of liver fibrosis influenced by serum alanine aminotransferase levels in patients with chronic hepatitis B].
    Chen XB; Zhu X; Chen LY; Chen EQ; Tang H
    Zhonghua Gan Zang Bing Za Zhi; 2011 Apr; 19(4):286-90. PubMed ID: 21586228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of alanine transaminase and hepatitis B virus DNA to predict liver cirrhosis in hepatitis B e antigen-negative chronic hepatitis B using transient elastography.
    Wong GL; Wong VW; Choi PC; Chan AW; Chim AM; Yiu KK; Chan HY; Chan FK; Sung JJ; Chan HL
    Am J Gastroenterol; 2008 Dec; 103(12):3071-81. PubMed ID: 19086958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreasing hepatitis B viral load is associated with a risk of significant liver fibrosis in hepatitis B e antigen positive chronic hepatitis B.
    Xie Q; Hu X; Zhang Y; Jiang X; Li X; Li J
    J Med Virol; 2014 Nov; 86(11):1828-37. PubMed ID: 25145769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review with meta-analysis: the proportion of chronic hepatitis B patients with normal alanine transaminase ≤ 40 IU/L and significant hepatic fibrosis.
    Chao DT; Lim JK; Ayoub WS; Nguyen LH; Nguyen MH
    Aliment Pharmacol Ther; 2014 Feb; 39(4):349-58. PubMed ID: 24387289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B patients.
    Wong GL; Wong VW; Choi PC; Chan AW; Chim AM; Yiu KK; Chan HY; Chan FK; Sung JJ; Chan HL
    Clin Gastroenterol Hepatol; 2009 Feb; 7(2):227-33. PubMed ID: 19121647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of Liver Inflammation in Asian Patients With Chronic Hepatitis B With Normal ALT and Detectable HBV DNA in Absence of Liver Fibrosis.
    Liu J; Wang J; Yan X; Xue R; Zhan J; Jiang S; Geng Y; Liu Y; Mao M; Xia J; Yin S; Tong X; Chen Y; Ding W; Huang R; Wu C
    Hepatol Commun; 2022 Apr; 6(4):855-866. PubMed ID: 34783181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.